NRIX•benzinga•
Leerink Partners Initiates Coverage On Nurix Therapeutics with Market Perform Rating, Announces Price Target of $16
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 17, 2025 by benzinga